Keisuke Tonogaki

Follow

Person

Osaka, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Azabenzimidazole derivative having AMPK-activating activity
- Patent number 10,093,670
- Issue date Oct 9, 2018
- Shionogi & Co., Ltd.
- Eiichi Kojima
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabenzimidazole derivative having AMPK-activating activity
- Patent number 9,567,330
- Issue date Feb 14, 2017
- Shionogi & Co., Ltd.
- Eiichi Kojima
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero ring-fused imidazole derivative having AMPK activating effect
- Patent number 9,133,186
- Issue date Sep 15, 2015
- Shionogi & Co., Ltd.
- Keisuke Tonogaki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclohexane derivative having NPY Y5 receptor antagonism
- Patent number 8,653,125
- Issue date Feb 18, 2014
- Shionogi Co., Ltd.
- Hiroshi Yoshida
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
AZABENZIMIDAZOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY
- Publication number 20170107219
- Publication date Apr 20, 2017
- Shionogi & Co., Ltd.
- Eiichi Kojima
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZABENZIMIDAZOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY
- Publication number 20140194420
- Publication date Jul 10, 2014
- Shionogi & Co., Ltd.
- Eiichi Kojima
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERO RING-FUSED IMIDAZOLE DERIVATIVE HAVING AMPK ACTIVATING EFFECT
- Publication number 20130184240
- Publication date Jul 18, 2013
- Shionogi & Co., Ltd.
- Keisuke Tonogaki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOHEXANE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISM
- Publication number 20120004227
- Publication date Jan 5, 2012
- Shionogi & Co., Ltd.
- Hiroshi Yoshida
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
- Publication number 20110028468
- Publication date Feb 3, 2011
- Shinonogi & Co., Ltd
- Masahiro Sakagami
- C07 - ORGANIC CHEMISTRY